Rigetti Stock Under $20: Headline Rally Masks Persistent Commercial Hurdles

What happened

Rigetti Computing shares have rallied under $20 following news of a potential $100 million CHIPS and Science Act funding award from the Commerce Department. The company's latest 108-qubit system now boasts 99.9% gate fidelity, yet that still leaves error rates roughly 1,000 times too high for commercially useful quantum advantage. While the funding letter of intent adds external validation, the DeepValue master report underscores that revenue remains tiny at $4.4 million in Q1 2026, while operating cash burn continues at $16.2 million per quarter. The stock is priced on milestone and funding headlines rather than on earnings power, with a base-case implied value of $18 per share. Key catalysts to watch include conversion of the CHIPS LOI into definitive agreements and on-time delivery of the C-DAC 108-qubit system in the second half of 2026.

Implication

Rigetti's under-$20 stock price reflects a funding headline and a product milestone, but the underlying business still burns over $16 million per quarter on just $4.4 million in revenue. The 99.9% fidelity figure, while improved, leaves error rates 1,000x too high for practical quantum advantage. Until the CHIPS LOI converts to cash and the C-DAC system ships on schedule, the stock remains a high-risk theme play. A disciplined approach is to wait for the $14 attractive entry point or an 8-K confirming definitive CHIPS terms with acceptable dilution. Position sizing should treat RGTI as a special situation, not a compounding business.

Thesis delta

The news of up to $100 million in potential CHIPS funding reinforces the policy tailwind but does not change the fundamental investment thesis that RGTI's valuation is driven by milestone expectations rather than revenue. The rally brings the stock closer to the trim-above level of $24, increasing the risk of mean-reversion if catalysts slip. The thesis shifts from 'wait for catalyst' to 'wait for a better risk/reward entry point or confirmed catalyst progress'.